Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series

Ann Intern Med. 2021 Sep;174(9):1332-1334. doi: 10.7326/M21-1451. Epub 2021 May 25.

Authors

Caoilfhionn M Connolly¹, Brian J Boyarsky¹, Jake A Ruddy¹, William A Werbel¹, Lisa Christopher-Stine¹, Jacqueline M Garonzik-Wang¹, Dorry L Segev¹, Julie J Paik¹

Affiliation

¹ Johns Hopkins University School of Medicine, Baltimore, Maryland.

No abstract available

Publication types

Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273
Adult
Antibodies, Viral / blood*
BNT162 Vaccine
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Female
Humans
Immunocompromised Host*
Male
Middle Aged
Musculoskeletal Diseases / immunology*
Prospective Studies
Rheumatic Diseases / immunology*
Risk Factors
SARS-CoV-2 / immunology
Spike Glycoprotein, Coronavirus / immunology
Young Adult

Substances

Antibodies, Viral
COVID-19 Vaccines
Spike Glycoprotein, Coronavirus
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine